Article

Eye bank to provide tissue for worldwide research, transplants

Memphis, TN-The National Eye Bank Center (NEBC), nowofficially open for business, offers a centralized location forproviding ocular tissue for transplant surgery and researchworldwide.

Operated by Tissue Banks International (TBI), the center was dedicated in April with a ceremony by Gerald J. Cole, president and chief executive officer of TBI, and Thomas O. Wood, MD, medical director of NEBC. The center opened in September and has already shipped 600 corneas throughout the country and overseas.

"If we operated for a full year at our current rate, it would be 2,000 (procedures)," Cole said. TBI's 14 community-based centers, which remain open for local donation retrieval work, previously averaged 400 each year.

Equipped with specular microscopes, slit-lamp microscopes, a microkeratome, and a femtosecond laser, the facility hopes to process 10,000 corneas each year and could double that capacity as demand grows.

The center offers pre-cut grafts for DLEK, ALK, and other specialty transplant procedures, and the tissue is shipped via FedEx to researchers in the United States and overseas within 24 hours.

Cole said the single central facility allows TBI to invest in more expensive equipment and highly skilled personnel, while maintaining compliance with increasingly stringent FDA requirements.

"With some of our more modest-sized eye banks that only have a staff of three or four people, separation of duties is kind of difficult when you're staffed 24 hours a day, 7 days a week," he said.

Corneal tissue designated for donation is excised in the field, immediately placed in preservation media, and transported to Memphis for evaluation and processing. If the tissue is not needed in the community from which it came, it is made available elsewhere, Cole said.

"We have [corneas] in the hands of our surgeons within 5 days or less," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.